Comprehensive Notes on Antibiotic Discovery, Production, and Resistance

Comparison of Traditional and Modern Antibiotic Discovery

• Traditional Discovery Era:     * Historical screening was a tedious, labor-intensive exercise requiring significant manual effort.     * Researchers screened for antibiotic-producing microorganisms within mixed samples (samples containing many different kinds of microorganisms).     * The Problem of Mixed Samples: If a sample exhibited a defect or an effect, it was impossible to tell which specific microorganism was responsible without intensive isolation.     * Process involved taking soil samples and working through them to find desired secondary metabolites.     * The Re-isolation Problem: A common frustration was seemingly finding a "new" antibiotic only to discover it was the same known antibiotic produced by a different bacteria.

• Bioprospecting:     * Definition: The talent-seeking process of scouting and looking for potential prospects in biological systems (e.g., looking for antibiotic producers in complex mixtures).

• Modern Era Prospecting (Computational Methods):     * In Silico Analysis:         * Computational study of gene clusters across several organisms.         * If a gene cluster is known to code for a specific production (e.g., ampicillin), scientists search the genomes of thousands of other microorganisms for that specific cluster.         * This determines the potential for production functionally before entering a wet lab.         * It allows scientists to plot groups (e.g., identifying $20,000$ bacteria with a specific cluster) to focus the search, rather than testing thousands of bacteria that might produce the antibiotic in inadequate quantities.     * Target-Based Design:         * Focuses on the specific protein structures that an antibiotic targets within a pathogen.         * Scientists analyze the pathogen to find target protein structures and then match them against active antibiotic structures (e.g., Beta-lactam rings).     * Virtual Screening and Molecular Docking:         * Training computers to create $2D$ or $3D$ models (prints) of active molecules.         * Using genetic engineering to understand the specific chemical groups (e.g., rings, amino acids) that make a structure active.         * Scientists screen millions of bacteria through databases to see if the designed molecular structure can "lock and match" with structures in that bacteria.

The Evolution of Bioinformatics

• Bioinformatics has become a massive field involving the modeling of biological and biochemical processes to save money and time.
• It allows academics to study the structures of working medicines and biological systems without the overhead of manual conventional microbiology.
• While it is the "new kid on the block," it requires a deep background in how microbes function to interpret the data correctly.

Traditional Isolation and Screening Procedures

• Initial Isolation Protocol:     * A soil sample is taken, spread, and plated onto growth media, followed by incubation.     * The mixed culture is then overlaid with a known pathogen.     * Researchers look for clearings, referred to as "zones of inhibition," around certain colonies the next morning.     * These clear zones indicate that the organism secreted an inhibitory compound or antibiotic that prevented the growth of the pathogen.

• Secondary Testing via Selective Media:     * Because the $Streptomyces$ species produces most known antibiotics, selective media is often used to target its growth.     * The organism that showed inhibition is isolated into a pure culture to test the breadth of its activity (cross-spectrum activity).

• Perpendicular Streaking (The Cross-Streak Method):     * The isolate is streaked horizontally in one direction on a new plate.     * It is allowed to grow (overnight or as required).     * Test organisms (several pathogens) are then streaked perpendicularly (in the opposite direction) across the original streak.     * If the pathogens fail to grow as they approach the isolate, it proves the isolate secretes a diffusible antibiotic.     * Testing against both gram-negative and gram-positive bacteria allows researchers to determine if the antibiotic has "broad-spectrum activity."

Characterization and Safety Testing

• Structural Analysis:     * NMR (Nuclear Magnetic Resonance) Spectroscopy: Used to determine the $3D$ atomic structure of the antibiotic.     * X-ray Crystallography: Helps study stability and how the molecule binds to targets.     * Information gained helps improve stability, solubility, and target-binding effectiveness.

• In Vitro Testing (Toxicity in Cell Lines):     * Testing is done at a small scale in the laboratory to ensure the antibiotic is not toxic to human cells.     * HeLa Cells: One of the oldest cell lines used; originally isolated from a woman with cervical cancer. They are used to study cancer drugs and general toxicity.     * HEK Cells (Human Embryonic Kidney): Used because many antibiotics tend to accumulate in the kidneys (e.g., aminoglycosides), making kidney toxicity a critical metric.     * CHO Cells (Chinese Hamster Ovary): Used for studying the effects of new drugs on mammalian systems.

• In Vivo Testing (Animal Trials):     * Mice and Rats: Used because their genomes and biological responses are close to humans.     * Zebrafish: Favored because they are transparent, allowing visual monitoring of the drug's path and initial processes in the system. They reproduce very quickly, ensuring they are not rendered extinct by testing.

• Clinical Trials and FDA Approval:     * The process of moving an antibiotic to market requires an investment of over $1 \times 10^9$ (one billion) US dollars.     * Phase 1: Small groups; tests for safety and effective dosage.     * Phase 2: Larger population; tests for efficacy and wider safety.     * Phase 3: Even wider population/diverse groups; comparisons against existing antibiotics.     * Importance of Transparency: The speaker notes a case where a drug was killing $3 \%$ of a test population ($30$ out of $1,000$); while that may seem small, it translates to $3,000,000$ (three million) deaths if prescribed to a larger population.

Industrial Production and Yield Optimization

• The Yield Problem: Microorganisms naturally produce antibiotics as secondary metabolites in tiny quantities (e.g., $0.01 \, μg$).     * Antibiotics are defense mechanisms/competitive tools used for survival in nutrient-scarce environments.     * Feedback Inhibition: Organisms have internal systems that stop production once a certain concentration is reached.

• Increasing Yield:     * Requires genetic engineering to mutate the genome so the bacteria overproduces.     * Scientists may move the gene cluster to a more efficient industrial producer strain.

• Downstream Processing:     * Antibiotics must be extracted from the fermentation broth via filtration or high-speed centrifugation.     * The product is purified and then crystallized to ensure stability.     * Pyrogens (LPS/Endotoxins):         * Lipopolysaccharides (LPS) are found on the outer membrane of gram-negative bacteria as protection.         * They are highly toxic to humans even in small doses.         * FDA requirements mandate that antibiotics must be "pyrogen-free."

Case Study: Penicillin Production

• Medium Choice: Corn Steep Liquor (CSL).     * A cheap byproduct of milling wet maize.     * Nutrient-rich: Contains nitrogen, vitamins, growth factors, minerals, and trace minerals.     * Replaces expensive supplements like yeast extract or peptone.
• Strain Improvement History:     * Original discovery by Alexander Fleming ($P. notatum$).     * Oxford researchers found $P. chrysogenum$ for better yields.     * In the $1940s$, prior to modern genetic engineering, scientists used intensive mutagenesis and random selection.     * They repeatedly selected the highest-yielding mutants, eventually reaching a massive yield of $50,000 \, mg/L$.     * Modern genetic engineering has not been able to improve significantly on this yield, only being used to study the structure of the antibiotic.

Penicillin Structure and Derivatives

• Basic Structure: Contains the Beta-lactam ring.
• Penicillin G: Must be administered intravenously; it is destroyed by gastric acid.
• Penicillin V: Contains an oxygen atom and benzene group making it "acid stable," allowing for oral administration.
• Dimethyl Group: Helps the penicillin molecule position itself and "launch" onto the Transpeptidase enzyme.
• Semi-Synthetic Penicillins:     * Created by adding chemical side chains to the natural penicillin structure during or after fermentation.     * Ampicillin and Amoxicillin: Created for broad-spectrum activity.     * Methicillin: Designed with chemical groups that defend against Beta-lactamase (or penicillinase), an enzyme used by bacteria like $Staphylococcus \, aureus$ to destroy the antibiotic.

Fermentation Parameters and Control

• Oxygenation: Most antibiotic-producing organisms (like $P. chrysogenum$) are "obligate aerobes." Low oxygen levels shut down production.
• Carbon Sources and Catabolite Repression:     * The Carbon Partition Rule: Approximately $65 \%$ of carbon goes to cellular maintenance, $25 \%$ to biomass growth, and only $10 \%$ to production.     * Glucose: A high-growth sugar that can cause "catabolite repression," where high levels of glucose signal the cell to stop producing secondary metabolites.     * Industry Strategies to Avert Repression:         1. Start with glucose for rapid biomass expansion, then switch to a "slow-growth" carbon like lactose or vegetable oil for the production phase.         2. Start with lactose for slow biomass growth, then add glucose at a very low feed rate to maintain the machine without triggering repression.

The Antibiotic Resistance Crisis

• Selective Pressure: Excessive use of antibiotics kills susceptible bacteria, leaving only the naturally resistant ones to reproduce (survival of the fittest).
• MRSA (Methicillin-Resistant $Staphylococcus \, aureus$):     * $S. aureus$ is described as a "champion" at resisting antibiotics.     * The speaker uses a metaphor: The enzymes they secrete are like "Zoro chopping back" at the Beta-lactam structures.     * Mechanism of Resistance: MRSA produces a different version of the PBP (Penicillin Binding Protein). The antibiotic enters the system but cannot bind to anything to exert its effect.
• VRSA (Vancomycin-Resistant $Staphylococcus \, aureus$): Particularly dangerous because Vancomycin is a "last resort" drug.
• Horizontal Gene Transfer (HGT): Bacteria share resistance genes quickly, even with idle bacteria in the human body.

Questions & Discussion

• Question from Shepo (referenced): Discussed the importance of oxygenation in the fermentation block, specifically that the process is strictly aerobic.
• Mini-Quiz Recap: Mentioned the importance of strictly aseptic vs. strictly aerobic conditions in industrial production.
• Consultation: The lecturer invites students to book consultations to handle the complexities of the subject before assessments.